CIDP has not been shown to attack organs of the body as other autoimmune diseases (ie: lupus) have.
CIDP is a type of neuropathy that breaks down the fatty covering on nerve endings.
Symptoms are almost always felt in the arms and legs; beginning as a tingling and/or numbness in the fingers and toes, with the possibilty for progression to encompass the entire limb.
CIPD is a treatable condition, with immunosupressant drugs. Most patients undergoing treatment receive an almost full reprieve on their symptoms.
Some patients, however, spontaneously recover fully on their own without the use of immunosupressants. While others go through phases of flare-ups and partial recoveries.
Bladder control can be affected because of having CIDP but it may not necessarily be a symptom of having it. Some patients with polyneuropathy conditions complain of a lack of bladder control.
i have ms and cidp. i am looking for other people who use hydrocodone or norco or vicodin
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurological disorder characterized by progressive weakness and impaired sensory function due to damage to the myelin sheath that insulates nerve fibers. It is believed to be an autoimmune condition, where the body's immune system mistakenly attacks the peripheral nerves. Symptoms often include muscle weakness, numbness, and fatigue, and they can vary in severity. Treatment typically involves immunotherapy, such as corticosteroids or intravenous immunoglobulin (IVIG), to reduce inflammation and improve nerve function.
IgG therapy is thought to help CIDP (chronic inflammatory demyelinating polyneuropathy) by reducing inflammation in the peripheral nerves and modifying the immune response. It can help to stabilize the condition and improve nerve function in some patients with CIDP.
Chronic inflammatory demyelinating polyneuropathy (CIDP) can affect individuals of any age, but it's more commonly diagnosed in adults, with a peak incidence between 40-60 years old. Both men and women are affected, although CIDP is slightly more prevalent in men. There is no specific racial or ethnic predilection for CIDP.
not in l.a. but one in palm springs
Yes, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is classified as an autoimmune disease. In CIDP, the immune system mistakenly attacks the peripheral nerves, leading to inflammation and damage to the myelin sheath that insulates these nerves. This results in symptoms such as weakness, numbness, and impaired motor function. Treatment often involves therapies aimed at modulating the immune response.
Yes. Perry was hospitalized in April, 2009 for Chronic Inflammatory Demyelinating Polyneuropathy, a disease that affects the nervous system and is a result of being afflicted with Guillain-Barre Syndrome, a disease where the immune system attacks the nerves causing weakness and numbness in the arms and legs. Perry was hospitalized for about 5 weeks and left the hospital to receive rehabilation at an undisclosed location.
Prolonged inflammation, healing of the tissue from the inflammatory process
polymyositis
Chronic inflammatory cell infiltrate in the fibromuscular tissue refers to a long-standing presence of immune cells, such as lymphocytes and macrophages, within the fibrous and muscle layers of an organ or tissue. This condition can be seen in chronic inflammatory disorders and may lead to tissue damage and dysfunction over time.
PID can recur, or can become chronic.
increase in eosinophil cell and plasma cell